How did SGHT's Q1 2024 EPS outperform forecasts?

Sight Sciences' (SGHT) Q1 2024 diluted EPS of -$0.33 underperformed the forecast by 0.05, missing the mark by 5.3%. This indicates a challenging quarter for the company, with earnings falling short of market expectations. The revenue for the quarter was $18.75 million, which was 0.95% below the analyst estimate. Despite these setbacks, the company's focus on maintaining revenue growth and reducing expenses suggests a strategic effort to improve financial health. The anticipated expansion into the European market could also signal a positive growth trajectory, potentially leading to improved financial performance in the future. |code|Ticker|Name|Date|Diluted EPS YoY|Diluted EPS|market_code| |---|---|---|---|---|---|---| |SGHT|SGHT.O|Sight Sciences|2023 Q2|40|-0.3|185| |SGHT|SGHT.O|Sight Sciences|2023 Q3|41.30434782608695|-0.27|185| |SGHT|SGHT.O|Sight Sciences|2024 Q1|5.714285714285704|-0.33|185|